Saturday, September 23, 2023
Saturday, September 23, 2023

Princeton Baptist Medical Center First Hospital in Alabama to Deploy 7D Surgical’s Machine-Vision Image Guided Surgery (MvIGS) Technology

As hospitals around the world look for new and innovative ways to improve surgical outcomes and patient safety, Princeton Baptist Medical Center has taken a leap into the future with the installation of the 7D Surgical FLASH™ Navigation System for spinal and cranial procedures by being the first hospital in Alabama to deploy the technology.

This system virtually replaces standard fluoroscopy, providing the surgical team with a fast, accurate and radiation-free tool for the placement of spinal implants.

“Princeton Baptist Medical Center has always been proactive in ensuring that we have the right tools to protect our patients and enhance neurosurgical patient care, which is why we supported the purchase of the 7D Surgical FLASH Navigation System,” said Mike Neuendorf, Princeton CEO. “This important investment underscores our commitment to patient care and the communities we serve, for both advanced spinal and cranial procedures.”

The 7D Surgical FLASH Navigation System is the first and only platform that utilizes Machine-Vision Image Guided Surgery (MvIGS) technology. For the first-time, spine surgeons can guide their tools to the critical anatomy using sophisticated camera technology linked to a computer in the operating theater. The underlying technology is similar to what is used in the latest self-driving automobiles. Unlike time-consuming conventional image guided surgery (IGS) systems that depend on intraoperative radiation, this new MvIGS technology can achieve an incredibly fast surgical workflow for spine procedures, reducing operative time for patients and eliminating unnecessary radiation exposure.

“As a Neurosurgeon, the FLASH Navigation System technology provides me with enhanced precision when placing hardware in the spine, because I can see the anatomy in 3D,” said Resit Cezayirli M.D., an affiliated neurosurgeon at Princeton Baptist Medical Center. “I am proud to offer my patients the latest technology in spine surgery while eliminating unnecessary radiation still used in many hospitals.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

FDA OK’s ensoETM for Use in Cardiac Ablations to Reduce Risk of Esophageal Injury

Published studies that have examined the use of ensoETM for this purpose include the pilot eCOOL-AF study, the IMPACT study and a large multi-center analysis of over 25,000 patients (in press at the Journal of the American College of Cardiology: Clinical Electrophysiology). These studies have found up to an 83 percent reduction in esophageal injuries, and a significant reduction in risk of atrioesophageal fistula (AEF), one of the most dreaded complications of ablation procedures.

Annalise.ai Receives FDA Clearance and Breakthrough Device Designation

Annalise.ai has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the FDA Breakthrough Devices Program.

By using this website you agree to accept Medical Device News Magazine Privacy Policy